Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3390)
All Articles published online
|
Jul 1, 2004 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi TD, Wu YZ, Jia ZC, Zou LY, Zhou W. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs. World J Gastroenterol 2004; 10(13): 1902-1906 [PMID: 15222033 DOI: 10.3748/wjg.v10.i13.1902] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i13/1902.htm |
| Number | Citing Articles |
| 1 |
Ernawati Arifin Giri-Rachman, Marselina Irasonia Tan, Ashwin Ramesh, Putri Ayu Fajar, Annisa Nurul Ilmi, Debbie Sofie Retnoningrum, Rukman Hertadi, Apriliani Irawan, Gladys Emmanuella Putri Wojciechowska, Lijuan Yuan. Development of Chimeric Hepatitis B (HBV) – Norovirus (NoV) P particle as candidate vaccine against Hepatitis B and norovirus infection. Vaccine: X 2023; 14: 100354 doi: 10.1016/j.jvacx.2023.100354
|
| 2 |
Wei Cao, Zhifeng Qiu, Ting Zhu, Yanling Li, Yang Han, Taisheng Li. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection. Journal of Clinical Virology 2014; 61(1): 40 doi: 10.1016/j.jcv.2014.06.022
|
| 3 |
Jianqiang Li, Mengru Bao, Jun Ge, Sulin Ren, Tong Zhou, Fengchun Qi, Xiuying Pu, Jia Dou. Research progress of therapeutic vaccines for treating chronic hepatitis B. Human Vaccines & Immunotherapeutics 2017; 13(5): 986 doi: 10.1080/21645515.2016.1276125
|
| 4 |
Yan Lin, Yu Dong, Yanfeng Gao, Ranran Shi, Yubing Li, Xiuman Zhou, Wenwen Liu, Guodong Li, Yuanming Qi, Yahong Wu, Youmin Kang. Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/8899674
|
| 5 |
Yaakov Maman, Antoine Blancher, Jennifer Benichou, Adi Yablonka, Sol Efroni, Yoram Louzoun. Immune-Induced Evolutionary Selection Focused on a Single Reading Frame in Overlapping Hepatitis B Virus Proteins. Journal of Virology 2011; 85(9): 4558 doi: 10.1128/JVI.02142-10
|
| 6 |
Murali Ganesan, Vjaceslav M. Krutik, Edward Makarov, Saumi Mathews, Kusum K. Kharbanda, Larisa Y. Poluektova, Carol A Casey, Natalia A. Osna. Acetaldehyde suppresses the display of HBV-MHC class I complexes on HBV-expressing hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(2): G127 doi: 10.1152/ajpgi.00064.2019
|
| 7 |
Azam Askari, Gholam Hossein Hassanshahi, Seyed Razi Ghalebi, Abdollah Jafarzadeh, Maryam Mohit, Masomeh Hajghani, Mohammad Kazemi Arababadi. Intensity of HLA-A2 Expression Significantly Decreased in Occult Hepatitis B Infection. Jundishapur Journal of Microbiology 2014; 7(6) doi: 10.5812/jjm.10298
|
| 8 |
J. Rajčáni, S. Szathmary. Peptide Vaccines: New Trends for Avoiding the Autoimmune Response. The Open Infectious Diseases Journal 2018; 10(1): 47 doi: 10.2174/1874279301810010047
|
| 9 |
Heng-Gui Liu, Wei-wei Chen, Zhen-Ping Fan, Hui-ying Yang, Ming Shi, Zheng Zhang, Shen-Shun Luan, Hui Zhang, Peng Lu, Po Tien, Fu-Sheng Wang. The high prevalence of the I27 mutant HBcAg18–27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clinical Immunology 2007; 125(3): 337 doi: 10.1016/j.clim.2007.06.010
|
| 10 |
Artur A. M. L. Brandt, Rodrigo N. Rodrigues-da-Silva, Josué C. Lima-Junior, Carlos R. Alves, Franklin de Souza-Silva, Sebastien Fiorucci. Combining Well-Tempered Metadynamics Simulation and SPR Assays to Characterize the Binding Mechanism of the Universal T-Lymphocyte Tetanus Toxin Epitope TT830-843. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5568980
|
| 11 |
Suna Wang, Qunying Han, Ni Zhang, Jinghong Chen, Zhengwen Liu, Guoyu Zhang, Zhu Li. HBcAg18–27 epitope fused to HIV-Tat49–57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice. Immunology Letters 2010; 127(2): 143 doi: 10.1016/j.imlet.2009.10.011
|
| 12 |
Sandra Phillips, Shilpa Chokshi, Antonio Riva, Alexander Evans, Roger Williams, Nikolai V. Naoumov. CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions. The Journal of Immunology 2010; 184(1): 287 doi: 10.4049/jimmunol.0902761
|
| 13 |
Nanna-Sophie Brinck-Jensen, Thomas Vorup-Jensen, Peter Derek Christian Leutscher, Christian Erikstrup, Eskild Petersen. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV. BMC Immunology 2015; 16(1) doi: 10.1186/s12865-015-0127-7
|
| 14 |
Dezhi Li, Zelong Dou, Yahong Wu, Yuanming Qi, Junhui Chen, Yanfeng Gao. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis. Protein & Peptide Letters 2020; 27(11): 1141 doi: 10.2174/0929866527666200505215346
|
| 15 |
Xing-bin Hu, Qiao-hong Yue, Hai-feng Ouyang, Yao-zhen Chen, Xue-qing Xu, Wen Yin, San-hua Wei, Xian-qing Zhang, Shi-jie Mu. Immune response to fused core protein of hepatitis C virus and truncated tetanus toxin peptides in mice. Archives of Virology 2010; 155(7): 1097 doi: 10.1007/s00705-010-0692-2
|
| 16 |
Murali Ganesan, Weimin Wang, Saumi Mathews, Edward Makarov, Moses New‐Aaron, Raghubendra Singh Dagur, Antje Malo, Ulrike Protzer, Kusum K. Kharbanda, Carol A. Casey, Larisa Y. Poluektova, Natalia A. Osna. Ethanol attenuates presentation of cytotoxic T‐lymphocyte epitopes on hepatocytes of HBV‐infected humanized mice. Alcoholism: Clinical and Experimental Research 2022; 46(1): 40 doi: 10.1111/acer.14740
|
| 17 |
Wonderful Tatenda Choga, Motswedi Anderson, Edward Zumbika, Bonolo B. Phinius, Tshepiso Mbangiwa, Lynnette N. Bhebhe, Kabo Baruti, Peter Opiyo Kimathi, Kaelo K. Seatla, Rosemary M. Musonda, Trevor Graham Bell, Sikhulile Moyo, Jason T. Blackard, Simani Gaseitsiwe. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020; 12(7): 731 doi: 10.3390/v12070731
|
| 18 |
Yutaka Tsutsumi, Hiroe Kanamori, Akio Mori, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Nobuo Masauzi. Reactivation of hepatitis B virus with rituximab. Expert Opinion on Drug Safety 2005; 4(3): 599 doi: 10.1517/14740338.4.3.599
|
| 19 |
Suna Wang, Qunying Han, Guoyu Zhang, Ni Zhang, Zhu Li, Jinghong Chen, Yi Lv, Na Li, Fanfan Xing, Ningqiang Tian, Qianqian Zhu, Zhengwen Liu. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase. International Immunopharmacology 2011; 11(4): 406 doi: 10.1016/j.intimp.2010.12.005
|
| 20 |
Fu-Qiang Yang, Gui-Rong Rao, Gui-Qiang Wang, Yue-Qi Li, Yao Xie, Zhan-Qing Zhang, Cun-Liang Deng, Qing Mao, Jun Li, Wei Zhao, Mao-Rong Wang, Tao Han, Shi-Jun Chen, Chen Pan, De-Ming Tan, Jia Shang, Ming-Xiang Zhang, Yue-Xin Zhang, Ji-Ming Yang, Guang-Ming Chen. Phase IIb trial of <i>in vivo</i> electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy. World Journal of Gastroenterology 2017; 23(2): 306-317 doi: 10.3748/wjg.v23.i2.306
|